AGC (5201) Q2 2025 earnings summary

Executive summary

• Net sales for 1H FY2025 were ¥995.5B, down 1.9% year-over-year, mainly due to yen appreciation and lower architectural glass shipments in Europe.

• Operating profit declined 4.7% to ¥54.0B, impacted by higher raw material and fuel costs despite some pricing improvements.

• Profit attributable to owners surged by ¥128.4B, reflecting the absence of prior-year losses from Russian business transfer and biopharma impairments.

• Downward revision of FY2025 outlook due to underperformance in Chemicals, Life Science, and Electronics segments.

• Profit before tax rose to ¥33.8B from a ¥92.4B loss a year earlier.

Financial highlights

• Operating profit margin for 1H FY2025 was 5.4%.

• Free cash flow for 1H FY2025 was ¥29.4B, down from ¥64.0B year-over-year.

• Basic earnings per share were ¥65.59, compared to a loss of ¥540.26 per share in the prior year.

• Total assets as of June 30, 2025, were ¥2,804.9B, down ¥84.8B from December 31, 2024.

• Interim dividend confirmed at ¥105 per share; full-year forecast unchanged at ¥210.

Outlook and guidance

• FY2025 net sales forecast revised to ¥2,050B (down ¥100B from previous), operating profit to ¥120B (down ¥30B), and profit attributable to owners to ¥57B.

• Segment outlook: Automotive and Performance Chemicals expected to grow, while Life Science and Electronics face headwinds.

• ROE target of 5% or higher in 2026, with structural reforms and cost reductions planned.

• Forecast revision announced, reflecting updated management assumptions and market conditions.